期刊文献+

噬菌体疗法在耐药性细菌感染中应用的研究进展 被引量:7

Advance research on application of bacteriophage therapy in drug resistant bacterial infections
下载PDF
导出
摘要 细菌耐药性已成为全球性的公共卫生问题,特别是"超级细菌"成员的不断增加使针对细菌感染的抗生素疗法面临前所未有的挑战。最近,噬菌体疗法重新受到人们的关注,并取得一些重要研究进展。本文作者就早期噬菌体的研究情况、近年来噬菌体疗法在动物实验中的应用、临床试验的最新实例和噬菌体疗法的优势及局限进行综述。
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2013年第3期630-633,共4页 Journal of Jilin University:Medicine Edition
基金 国家自然科学基金委主任基金资助课题(81150037)
  • 相关文献

参考文献34

  • 1Kumarasamy KK,Toleman MA,Walsh TR,et al.Emergence of a new antibiotic resistance mechanism in India,Pakistan,and the UK:a molecular,biological and epidemiological study[J].Lancent Infec Dis,2010,10(9):597-602.
  • 2黄留玉.关于超级细菌NDM-1的若干思考[J].解放军医学杂志,2010,35(12):1409-1411. 被引量:20
  • 3朱德妹,汪复,胡付品,蒋晓飞,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,陈中举,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,王爱敏,张泓,孔菁,徐元宏,沈继录,单斌,杜艳.2010年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2011,11(5):321-329. 被引量:651
  • 4Twort FW.An investigation on the nature of ultra-microscopic viruses[J].Lancet,1915,186(4):1241-1243.
  • 5d’Herelle F.On an invisible microbe antagonistic to dysentery bacilli[J].Comptes Rendus Acad Des Sci,1917,165(3):373-375.
  • 6Brussow H,Kutter E.Bacteriophages:biology and applications[M].Florida:CRC Press,2005:129-163.
  • 7Maura D,Debarbieux L.Bacteriophages as twenty-first century antibacterial tools for food and medicine[J].Appl Microbiol Biotechnol,2011,90(3):851-859.
  • 8Summers WC.Bacteriophage therapy[J].Annu Rev Micriobiol,2001,55(1):437-451.
  • 9Sulakvelidze A,Alavidze Z,Morris JG Jr.Bacteriophage therapy[J].Antimicrob Agents Chemother,2001,45(3):649-659.
  • 10Slopek SB,Weber-Dabrowska BM,Dabrowski M,et al.Results of bacteriophage treatment of suppurative bacterial infections in the years1981-1986[J].Arch Immunol Ther Exp,1987,35(5):569-583.

二级参考文献31

  • 1吕星,郭文学,王淑香,宋诗铎.天津市某医院2002-2003年临床分离金黄色葡萄球菌耐药谱及MRSA流行趋势分析[J].中国感染控制杂志,2006,5(2):172-173. 被引量:23
  • 2Arias CA,Murray BE.Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J].N Engl J Med,2009,360(5):439-443.
  • 3Clinical and Laboratory Standads Institute.Performance Standards for Antimicrobial Susceptibility Testing[S].Fifteenth Informational Supplement,2010,M100-S20 Vol 30 No.1.
  • 4Clinical and Laboratory Standads Institute Performance Standards for Antimicrobial Susceptibility Testing[S].Fifteenth Informational Supplement,2010,M100-S20-U Vol 30 No 15.
  • 5Clinical Laboratory Standard Institute.Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria[S].Approved Guideline M45-A,Vol.26 No.19,2006.
  • 6Wang P,Hu FP,Xiong ZZ,et al.Susceptibility of ESBL-Producing nterobacteriaceae with the New CLSI Breakpoints[J].J Clin Microbiol,2011,49(6):3127-3131.
  • 7Yang Q,Wang H,Sun H,et al.Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems:results from large hospital-based surveillance studies in China[J].Antimicrob Agents Chemother,2010,54(1):573-577.
  • 8Wang H.Guo P,Sun HL,et al.Molecular epidemiology of clinical isolates of carbapenem-resistant Acinerobacter spp from Chinese hospitals[J].Antimicrob Agents Chemother.2007,51(11):4022-4028.
  • 9Shorr A F. Epidemiology of staphylococcal resistance [J]. Clin Infect Dis, 2007,45 (Suppl 3) :S171-S176.
  • 10Hardy K J, Hawkey P M, Gao F, et al. Methicillin resistant Staphylococcus aureus in the critically ill [ J]. Br J Anaesth, 2004, 92( 1 ) : 121-130,

共引文献681

同被引文献72

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部